NCT02289599View on ClinicalTrials.gov

A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy Subjects
Interventions
DRUG

E2307

DRUG

E2307 Matching Placebo

Trial Locations (1)

Unknown

Kagoshima

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02289599 - A Study to Assess Safety, Tolerability, and Pharmacokinetics of E2307 in Healthy Young and Elderly Japanese Subjects | Biotech Hunter | Biotech Hunter